H.U.Group Holdings,Inc.(4544) News

Notice Concerning Nominees for Directors and Auditors of Major Subsidiaries

Notice Concerning Appointment of Executive Officers

Notice Concerning Nominees for Directors

Corporate Governance Report

Selected under KENKO Investment for Health for Third Consecutive Year and Certified under 2026 Outstanding Organizations of KENKO Investment for

Notice Concerning Change of Major Shareholder

Change of Executive Officers of the Company and Directors of its Major Subsidiaries

Notice Concerning Disposal of Treasury Shares as Stock Compensation

[Summary]Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

Notice Concerning the Revisions of the Full-Year Consolidated Earnings Forecast

Notice Concerning Change of Representative Executive Officer

Selected for Inclusion in Morningstar Japan ex-REIT Gender Diversity Tilt Index with the Highest Rating for the third consecutive year

H.U.Group Integrated Report 2025

Application for Manufacturing and Marketing Authorization in Japan for Blood-Based IVD Test to Aid in Identifying Amyloid Pathology Associated with AD

Corporate Governance Report

[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)

Notice Concerning the Status and Completion of the Acquisition of Treasury Stock

Notice Concerning the Status of the Acquisition of Treasury Stock

Introduction of the Stock Grant ESOP Trust

Notice Concerning Recording of Extraordinary Income Related to Sale of Non-current Assets and Shares, and Revision to Full-year Consolidated Earnings